Clinical Trial Update: Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma [NA]

View source ↗

Summary

A Phase III randomized trial is evaluating the role of involved mediastinal radiotherapy after Rituximab-containing chemotherapy in newly diagnosed primary medi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mediastinal Large B-cell Lymphoma

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: International Extranodal Lymphoma Study Group (IELSG) | Conditions: Primary Mediastinal B-cell Lymphoma | NA | Status: ACTIVE_NOT_RECRUITING